{
    "title": "COVID-19 vaccine developer CureVac shares more than triple after U.S. debut",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8628405/Coronavirus-vaccine-developer-CureVac-shares-surge-175-Nasdaq-debut.html",
    "date": "2020-08-14",
    "keywords": [
        "company",
        "vaccine",
        "curevac",
        "share",
        "rebecca",
        "spalding",
        "zainab",
        "hussain",
        "stock",
        "market",
        "price",
        "haas",
        "candidate",
        "government",
        "june",
        "stake",
        "biotechnology",
        "firm",
        "debut",
        "friday",
        "opening",
        "novel",
        "session",
        "high",
        "trade",
        "offering",
        "officer",
        "franzwerner",
        "cash",
        "hand",
        "manufacturing",
        "capacity",
        "order",
        "demand",
        "mid2021",
        "world",
        "purchase",
        "house",
        "tuesday",
        "deal",
        "competitor",
        "moderna",
        "end",
        "range",
        "smith",
        "principal",
        "renaissance",
        "capital",
        "provider",
        "research",
        "ipo",
        "earlystage",
        "coronavirus",
        "trial",
        "quarter",
        "month",
        "glaxosmithkline",
        "qatar",
        "investment",
        "authority",
        "reporting",
        "niket",
        "nishant",
        "bengaluru",
        "york",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}